Delivery Order SPE2DR25D1106-SPE2DR26FJK4B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,400.08 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed price, non-set-aside competitive award to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,950.24 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December...
- The Defense Logistics Agency awarded a $4,446.72 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promethegan 25 mg suppositories in quantities of 12 units. The order, valued at $2,577.42 with a firm fixed price structure, represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $3,900.48 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,746.59 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) with a completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,335.72 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 units) on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as a child...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJK4BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,079.72 to AmerisourceBergen Drug Corp for the supply of Promethegan 25 mg suppositories (12-count units) on January 28, 2026, with completion scheduled for January 29, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, maintains an extensive portfolio of medical product deliveries through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract awards demonstrate capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Promethegan suppositories represents a routine procurement of a gastrointestinal/antiemetic medication through the established IDC framework, supporting the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems requiring consistent access to pharmaceutical commodities for troop support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/27/26 |